Clorox (NYSE:CLX – Get Free Report) had its target price dropped by stock analysts at Jefferies Financial Group from $152.00 to $151.00 in a report released on Wednesday,MarketScreener reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price objective indicates a potential upside of 28.83% from the company’s current price.
A number of other equities analysts also recently commented on the stock. Wall Street Zen downgraded shares of Clorox from a “hold” rating to a “sell” rating in a report on Saturday, January 24th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating for the company in a research report on Friday, January 16th. Morgan Stanley dropped their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. The Goldman Sachs Group lowered their target price on Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a report on Wednesday, January 7th. Finally, Wells Fargo & Company raised their price target on Clorox from $108.00 to $115.00 and gave the stock an “equal weight” rating in a report on Friday, January 23rd. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $118.67.
View Our Latest Research Report on Clorox
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The business’s revenue for the quarter was down .8% on a year-over-year basis. During the same period in the prior year, the business earned $1.55 EPS. As a group, research analysts predict that Clorox will post 7.15 EPS for the current year.
Insider Buying and Selling
In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The stock was bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.63% of the company’s stock.
Institutional Investors Weigh In On Clorox
A number of hedge funds have recently bought and sold shares of CLX. Savvy Advisors Inc. boosted its position in shares of Clorox by 1.4% in the second quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after acquiring an additional 91 shares during the period. Canandaigua National Bank & Trust Co. grew its position in Clorox by 0.8% during the third quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after buying an additional 94 shares in the last quarter. State of Michigan Retirement System grew its holdings in shares of Clorox by 0.3% during the 2nd quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock worth $4,028,000 after purchasing an additional 100 shares in the last quarter. Field & Main Bank raised its position in Clorox by 3.3% in the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares in the last quarter. Finally, Fisher Asset Management LLC raised its holdings in shares of Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after buying an additional 102 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.
Clorox News Roundup
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Revenue slightly topped Street expectations and operating cash flow showed improvement versus a year ago, giving some near-term fundamental support. Clorox Company (CLX) Stock Falls on Q2 2026 Earnings
- Positive Sentiment: Bullish write-ups argue valuation (forward P/E ~18) and dividend yield make CLX attractive for income investors if management can stabilize volumes and margins. The Clorox Company (CLX): A Bull Case Theory
- Neutral Sentiment: Management hosted its Q2 earnings call and confirmed its outlook; read the transcript for detail on pricing, cost actions and working-capital plans. Q2 2026 Earnings Call Transcript
- Neutral Sentiment: Company press release reiterated results and the outlook — confirmation reduces surprise risk but left execution questions. Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook
- Negative Sentiment: Adjusted EPS missed consensus ($1.39 vs. ~$1.43), driven by higher costs and weaker volume in core cleaning categories — a clear short-term headwind for the share price. Clorox misses quarterly profit estimates
- Negative Sentiment: Management warned of an inventory reset in 2026 that could squeeze profits further — this forward-looking risk is a significant reason for near-term caution. Clorox Faces Profit Squeeze From Inventory Reset In 2026
- Negative Sentiment: Analysts and media highlighted muted demand and shoppers trading down to cheaper alternatives; some shops have cut targets and at least one major firm has an underweight view — pressure on consensus estimates may persist. Clorox Posts Lower Profit on Sales Volume Declines
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
- Five stocks we like better than Clorox
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Which stock will the White House buy next?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
